Biotech Chiefs Slam U.S. Report on Gene Patents
| February 6, 2010 |  View for printing |
Anticipating a series of federal recommendations on gene patents coming out tomorrow, a former Senator and four executives at biotech companies and biotech trade groups criticized the Department of Health and Human Services (HHS) for taking, they said, a stand that would undermine the the technology transfer objectives of the Bayh-Dole Act and the biotech industry generally in the United States.
Based on draft proposals, HHS's Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) is expected to issue six recommendations. The first is the most contentious, suggesting that Congress should enact laws to exempt gene patents from infringement liability—potentially allowing anyone to use any gene patent.
by Sam Kean
Full Story: http://blogs.sciencemag.org/sciencei ... xecs-s.html
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
